CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 755,028 | $1,736,564 | 0.43% |
| Monaco Asset Management SAM | 359,739 | $827,400 | 0.24% |
| Slate Path Capital LP | 2,402,455 | $5,525,647 | 0.15% |
| SANDERS MORRIS HARRIS LLC | 346,212 | $713,426 | 0.15% |
| ADVISORY RESEARCH INC | 257,225 | $591,618 | 0.08% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,100,550 | 0.07% |
| Annandale Capital, LLC | 65,000 | $150 | 0.04% |
| Good Life Advisors, LLC | 112,000 | $257,600 | 0.03% |
| CARLSON CAPITAL L P | 135,000 | $310,500 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 57,888 | $133,142 | 0.02% |
| Sigma Planning Corp | 244,705 | $562,822 | 0.02% |
| XTX Topco Ltd | 53,270 | $122,521 | 0.02% |
| CHANNEL WEALTH LLC | 15,300 | $35,190 | 0.02% |
| Nantahala Capital Management | 26,760 | $61,548 | 0.01% |
| Newbridge Financial Services Group, Inc. | 4,000 | $9,200 | 0.01% |
| Wedmont Private Capital | 20,000 | $40,800 | 0.00% |
| SeaCrest Wealth Management, LLC | 14,000 | $32,200 | 0.00% |
| Baker Avenue Asset Management, LP | 32,378 | $74,469 | 0.00% |
| Gleason Group, Inc. | 6,000 | $13,800 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
External links
This page lists CUE BIOPHARMA INC's shareholders in Q3 2023. To view CUE BIOPHARMA INC's shareholder history, click here.